Bulletin
Investor Alert

Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 23, 2022, 7:34 p.m.

/zigman2/quotes/201168308/composite

$

5.56

Change

-0.01 -0.18%

Volume

Volume 5,782

Quotes are delayed by 20 min

/zigman2/quotes/201168308/composite

Previous close

$ 6.25

$ 5.57

Change

-0.68 -10.88%

Day low

Day high

$5.45

$6.08

Open

52 week low

52 week high

$5.25

$51.95

Open

Annual Financials for Syros Pharmaceuticals Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries (54.01M)(62.28M)(75.44M)(84.04M)(86.56M)
Depreciation, Depletion & Amortization 1.53M1.6M2.72M3.04M3.02M
Depreciation and Depletion 1.53M1.6M2.72M3.04M3.02M
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds 4.32M5.97M8.71M11.55M(5.4M)
Funds from Operations (48.17M)(54.71M)(64.01M)(69.45M)(88.94M)
Extraordinaries -----
Changes in Working Capital 3.44M14.39M3.75M12.09M(10.6M)
Receivables 867,000-(20.16M)17.83M(648,000)
Accounts Payable 141,000888,0001.49M(1.06M)48,000
Other Assets/Liabilities (1.1M)9.31M26M(5.28M)(14.83M)
Net Operating Cash Flow (44.73M)(40.32M)(60.25M)(57.36M)(99.54M)

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures (821,000)(1.38M)(12.64M)(3.34M)(1.25M)
Capital Expenditures (Fixed Assets) (821,000)(1.38M)(12.64M)(3.34M)(1.25M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -9,000110,000--
Purchase/Sale of Investments (14.77M)(9.27M)794,00050M(51.41M)
Purchase of Investments (41.77M)(96.77M)(108.21M)-(51.41M)
Sale/Maturity of Investments 27M87.5M109M50M-
Other Uses -----
Other Sources -----
Net Investing Cash Flow (15.59M)(10.64M)(11.73M)46.66M(52.65M)

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 34.11M69.13M66.2M103.78M70.78M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 34.11M69.13M66.2M103.78M70.78M
Proceeds from Stock Options 34.11M69.13M66.2M103.78M70.78M
Other Proceeds from Sale of Stock -----
Issuance/Reduction of Debt, Net (168,000)(50,000)(205,000)39.17M(265,000)
Change in Current Debt -----
Change in Long-Term Debt (168,000)(50,000)(205,000)39.17M-
Issuance of Long-Term Debt ---39.41M-
Reduction in Long-Term Debt (168,000)(50,000)(205,000)(241,000)(265,000)
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 33.94M69.08M65.99M142.95M70.51M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash (26.38M)18.13M(6M)132.25M(81.68M)
Free Cash Flow (45.55M)(41.7M)(72.89M)(60.7M)(100.79M)
Link to MarketWatch's Slice.